Pentachlorophenol

Pentachlorophenol

SCHEMBL3345544

Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl.[Nb]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 8/20 0.91
TSHR P16473 7/20 0.91
HPGD P15428 7/20 0.91
ALDH1A1 P00352 3/20 0.91
MEN1 O00255 2/20 0.91
LMNA P02545 2/20 0.91
MAPT P10636 2/20 0.91
KMT2A Q03164 2/20 0.91
CYP1A2 P05177 4/20 0.50
CYP2C9 P11712 4/20 0.50
HIF1A Q16665 3/20 0.50
CASP1 P29466 1/20 0.47
CYP2C19 P33261 1/20 0.43
MAPK1 P28482 3/20 0.42
CYP3A4 P08684 5/20 0.40
USP2 O75604 1/20 0.40
TP53 P04637 1/20 0.40
GLA P06280 1/20 0.40
THRB P10828 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentachlorophenol SCHEMBL9824615 0.96 HSD17B10 (0.83) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL9278707 0.96 HSD17B10 (0.83) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL15329277 0.96 HSD17B10 (0.83) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL5315995 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL1492 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL23121452 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Perchlorobenzene SCHEMBL28269084 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL1330735 0.95 HSD17B10 (1.00) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL21177789 0.91 HSD17B10 (0.91) HSD17B10TSHRHPGDALDH1A1MEN1
Pentachlorophenol SCHEMBL11459279 0.91 HSD17B10 (0.91) HSD17B10TSHRHPGDALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116750809-A Modified ternary positive electrode material and preparation method thereof 新乡天力锂能股份有限公司 2023-09-15 CN claimed
CN-120127148-A Lithium iron phosphate-based positive electrode material, preparation method thereof and battery 深圳市德方纳米科技股份有限公司 2025-06-10 CN disclosed
US-20220149428-A1 PRECURSOR SOLUTION OF SOLID ELECTROLYTE SEIKO EPSON CORPORATION (JP) 2022-05-12 US disclosed
CN-113574019-A Precursor solution of solid electrolyte 精工爱普生株式会社 2021-10-29 CN disclosed
CN-107604135-B Carbon steel material before heat treatment having excellent scale removal property, carbon steel material after heat treatment, and method for producing same 日本帕卡濑精株式会社 2020-11-10 CN disclosed
WO-2020149261-A1 FLEXIBLE TUBE FOR ENDOSCOPE, ENDOSCOPIC MEDICAL DEVICE, AND MANUFACTURING METHODS THEREFOR 富士フイルム株式会社 2020-07-23 WO disclosed
EP-3322532-A1 TA-NB CATALYST FOR THE PRODUCTION OF 1,3-BUTADIENE IFP Energies nouvelles (FR) 2018-05-23 EP disclosed
US-20100159128-A1 Niobium 2-ethylhexanoate derivative, method of producing the derivative, organic acid metal salt composition containing the derivative, and method of producing thin film using the composition YOSHINAKA ATSUYA 2010-06-24 US disclosed
US-20090136658-A1 Niobium 2-Ethylhexanoate Derivative, Method Of Producing The Derivative, Organic Acid Metal Salt Composition Containing The Derivative, And Method Of Producing Thin Film Using The Composition ADEKA CORPORATION (JP) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090136658-A1 Niobium 2-Ethylhexanoate Derivative, Method Of Producing The Derivative, Organic Acid Metal Salt Composition Containing The Derivative, And Method Of Producing Thin Film Using The Composition HDHD5, HAO2, CA2 HSD17B10 653/4885TSHR 4082/4885HPGD 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.